"Why is it that patients who take prednisone, insulin...and a myriad of other medications daily or regularly to manage ...
The National Institute for Health and Care Excellence (NICE) has approved fenfluramine (Fintepla) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in people aged 2 years and ...
Latest research shows how cannabis-derived medication helps Alzheimer's patients manage agitation, offering fresh hope to ...
The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.
The drug is the first non-cannabinoid option for patients with LGS and an alternative to Jazz Pharma's Epidyolex (cannabidiol ...
For years, Texans living with conditions like PTSD, neuropathy, cancer and spasticity have had limited treatment options. Now ...
New life-changing treatment option fenfluramine recommended for type of rare epilepsy, Lennox–Gastaut syndrome ...
Starting today, the National Institute for Health and Care Excellence (NICE) has recommended the funding of fenfluramine for NHS patients in England. This new drug is specifically approved for ...
Irish Examiner on MSN4d
Irish neurologists prescribing cannabis as treatment for MS and other medical conditionsNeurologists in Ireland have revealed they are prescribing cannabis-based medicines for symptoms such as pain and spasticity ...
A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback